Related Experiment Video
Updated: Apr 23, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Psychiatric implications of cancer genetic testing
April Malia Hirschberg1, Gayun Chan-Smutko, William F Pirl
1Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
Genetic testing for hereditary cancers can cause temporary psychological distress, which usually lessens within a year. However, some individuals may experience lasting distress, with baseline distress being a key predictor.
Area of Science:
- Genetics
- Psychology
- Oncology
Background:
- Genetic testing for hereditary cancer syndromes is increasingly common in clinical practice.
- This shift necessitates understanding the psychosocial impact on individuals undergoing testing.
Purpose of the Study:
- To examine the psychological distress associated with genetic testing for hereditary cancer syndromes.
- To identify risk factors for both short-term and long-term psychological distress.
Main Methods:
- Review of existing research on psychosocial effects of genetic cancer testing.
- Analysis of distress levels at various time points post-testing (immediate, 12 months, 18 months to 8 years).
Main Results:
- Psychological distress generally decreases within the first year post-testing and is often not clinically significant.
- Longer-term studies show varied results, with some mutation carriers experiencing persistent elevated distress.
- Pre-existing distress is the most significant risk factor for both immediate and long-term psychological distress.
Conclusions:
- While distress often subsides, some individuals require ongoing psychosocial support.
- Identifying baseline distress and other risk factors is crucial for targeted interventions.
- Clinical care models need to adapt to support the growing population at risk for hereditary cancers.
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cancer Prevention
Some...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Survival Analysis
Psychoneuroimmunology: Diabetes and Cancer
